Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Nitrates or nitrites or nitric acid or nitrogen oxides
Reexamination Certificate
2007-06-26
2007-06-26
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Nitrates or nitrites or nitric acid or nitrogen oxides
C128S203120, C424S001130, C424S600000, C514S771000, C514S788000, C514S929000, C514S958000, C514S959000, C604S023000
Reexamination Certificate
active
10517723
ABSTRACT:
Xenon or xenon-containing gases and, where appropriate, an NO source are employed as medicament for cerebral protection. Cerebral protection is defined as reducing or preventing impairments of cerebral function of various causes, but especially secondary to perfusion impairments of unclear etiology. The medicament can be used for cerebral protection for the prophylaxis of impairments of cerebral perfusion and for therapy after cerebral disorders have occurred, irrespective of the cause (e.g. cognitive, sensory or motor in nature).
REFERENCES:
patent: 4292603 (1981-09-01), Hutchinson
patent: 5228434 (1993-07-01), Fishman
patent: 5670177 (1997-09-01), Briend et al.
patent: 6197323 (2001-03-01), Georgieff
patent: 2002/0033174 (2002-03-01), Lecourt et al.
patent: 199 10 986 (2000-09-01), None
patent: WO 00/53192 (2000-09-01), None
patent: 199 33 704 (2001-02-01), None
patent: 199 38 800 (2001-02-01), None
patent: 0 523 315 (1993-01-01), None
patent: 2 538 704 (1984-07-01), None
patent: WO 97/15311 (1997-05-01), None
patent: 2 812 545 (2002-02-01), None
patent: WO 98 40083 (1998-09-01), None
patent: WO 00/76545 (2000-12-01), None
patent: WO 02 09731 (2002-02-01), None
patent: WO 02 22116 (2002-03-01), None
patent: WO 02 22141 (2002-03-01), None
patent: WO 02 078863 (2002-10-01), None
Kuebler et al. Neuroscience Letters 2003, 348, 85-88.
Vavilala et al. Anesth Analg 2001, 93, 351-3.
Webster N R et al.: “Xenon Increases Arterial Pressure in Anaesthesized Rats” British Journal of Anaesthesia, Bd. 83, Nr. 1, Jul. 1999, Seiten 181P-182P, XP001056315; Seite182P, Absatz 2-4.
Franks N P et al: “How does Xenon produce Anaesthesia?” Nature, Macmillan Journals Ltd. London, GB, Bd. 396, Nr. 6709, Nov. 26, 1998, Seite 324 XP00096077; ISSN: 0028-0836 gesamtes Dokument.
Database Inspec [online] Institute of Electrical Engineers, Stevenage, GB; Kashiwagi's Et al: “Measurement and imaging of cerebral blood flow with stable xenon and computed tomography (Xe-CT)” Database accession No. 2912077 XP002191541 Zusammenfassung & Electromedica, 1986, West Germany, Bd. 54, N4. 4, Seiten 136-144, ISSN: 0013-4724.
Giunta, et al. “Xenon: A review of its Anaesthetical and Pharmacological Properties”, pp. 95-103 (Jun. 1996).
Neu Peter
Pilger Carsten
Reyle-Hahn Matthias
Air Liquide Deutschland GmbH
Arnold Ernst
Richter Johann
LandOfFree
Cerebral protection with a gas comprising xenon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cerebral protection with a gas comprising xenon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cerebral protection with a gas comprising xenon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3885322